Entry Detail


General Information

Database ID: LDA0007587
Species: Homo sapiens
Confidence Score: 0.731059
Contents: >> ncRNA Information
>> ncRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference
Causality: Yes
Clinical Significance: Unknown

 


ncRNA Information

Reference Genome Note: GRCh38 for human lncRNAs; GRCm39 for mouse lncRNAs; mRatBN7.2 for rat lncRNAs; hg19 for human circRNAs; mm9 for mouse circRNAs.

ncRNA Symbol:OIP5-AS1
Full Name:OIP5 antisense RNA 1
Category:LncRNA
Species:Homo sapiens
Synonyms:cyrano|linc-OIP5
Chromosome:15
Strand:+
Coordinate:
Start Site(bp):41282697End Site(bp):41313338
External Links:
Ensembl ID:ENSG00000247556
Ensembl Transcript ID:N/A
Entrez Gene:729082.0
NONCODE ID:N/A
RefSeq Accession:N/A

 

ncRNA Association Statistics

Total Associated Disease Number:68   
More Information
Causal Disease Number:62
Network:
Top Causal Diseases:
Breast Neoplasms  (Score: 1)
Uterine Cervical Neoplasms  (Score: 1)
Breast Neoplasms  (Score: 1)
Stomach Neoplasms  (Score: 1)
Uterine Cervical Neoplasms  (Score: 1)
Stomach Neoplasms  (Score: 1)
Lung Neoplasms  (Score: 0.999893)
Lung Neoplasms  (Score: 0.999893)
Osteosarcoma  (Score: 0.985791)
Squamous Cell Carcinoma of Head and Neck  (Score: 0.985791)
More Information

 

 

Disease Information

 Disease OntologyMeSH
Disease ID:DOID:437D009157
Disease Name:myasthenia gravisMyasthenia Gravis
Category:Disease OntologyMeSH
Type:Neoplasms
Define:An autoimmune disease of the nervous system that has_material_basis_in antibodies to acetylcholine receptors at the neuromuscular junction, has_symptom ptosis, has_symptom diplopia, has_symptom dysphagia, has_symptom dysarthria, has_symptom muscle weakness and has_symptom shortness of breath.A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Alias:Myasthenia Gravis//Myasthenia Gravis, Ocular//Ocular Myasthenia Gravis//Myasthenia Gravis, Generalized//Generalized Myasthenia Gravis//Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis//Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis//Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis//Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis//MuSK MG//MuSK Myasthenia Gravis//Myasthenia Gravis, MuSK//Anti-MuSK Myasthenia Gravis//Anti MuSK Myasthenia Gravis//Myasthenia Gravis, Anti-MuSK

 

Disease Association Statistics

Total Associated ncRNA Number:20   
More Information
Causal ncRNA Number:6
Network:
Top Causal ncRNAs:
LINC00680  (Score: 0.731059)
circFBL  (Score: 0.731059)
OIP5-AS1  (Score: 0.731059)
LINC00680  (Score: 0.731059)
circFBL  (Score: 0.731059)
OIP5-AS1  (Score: 0.731059)
More Information

 

Evidence Support

Strong Evidence:Western Blot//Transfection//qRT-PCR//Luciferase Report Assay//Cell Apoptosis Assay//Cell Proliferation Assay
Weak Evidence:

 

Reference

[1] PubMed ID:35602889
Disease Name:Myasthenia Gravis
Sample:patients with MG, Jurkat cell
Dysfunction Pattern:Interaction(miR-181c-5p/IL-7)
Validated Method:Western Blot//Transfection//qRT-PCR//Luciferase Report Assay//Cell Apoptosis Assay//Cell Proliferation Assay
Description: The expression of OIP5-AS1 was up-regulated in patients with MG. Luciferase reporter assay indicated that OIP5-AS1 targeted the miR-181c-5p. Mechanistically, knockdown of OIP5-AS1 inhibited IL-7 expression at both the mRNA and protein levels in Jurkat cells, whereas the miR-181c-5p inhibitor blocked the reduction of IL-7 expression induced by OIP5-AS1 suppression.
Causality:Yes
Causal Description:Functional assays showed that OIP5-AS1 suppressed Jurkat cell apoptosis and promoted cell proliferation by sponging miR-181c-5p.
Clinical-realted Application: